ABBV R&D to Revenue
AbbVie · R&D to Revenue
ABBV R&D to Revenue
Latest reported14.87%period ending
ABBV FY R&D/Revenue (12.01% → 14.87%)
Latest values, visible window
High-resolution chart · PNG
ABBV r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.8725% | |
| 22.7056% | |
| 14.1298% | |
| 11.2137% | |
| 14.3175% | |
| 16.9308% | |
| 20.4172% | |
| 32.8306% | |
| 18.9042% | |
| 17.8836% | |
| 19.4015% | |
| 18.2816% | |
| 16.9931% | |
| 16.6812% | |
| 18.8661% | |
| 17.9563% | |
| 12.0122% |